FREE PREVIEW. AAFP members and paid subscribers: Log in to get free access. All others: Purchase online access.

FREE PREVIEW. Purchase online access to read the full version of this article.

Am Fam Physician. 2002 Jun 15;65(12):2436-2438.

Information in the article “Preventive Strategies in Chronic Liver Disease” (November 1, 2001, page 1555) regarding seroconversion rates in hepatitis immunization was misleading. The first full paragraph in the left column on page 1557 should have been worded this way: “In patients without chronic liver disease, seroconversion occurs in 94 percent of patients following hepatitis A vaccination and 100 percent of patients following hepatitis B vaccination. Vaccination of adults with chronic liver disease of viral or nonviral etiology produced seroprotection rates similar to those observed in healthy adults.22 However, seroconversion rates are lower in patients older than 40 years, in those with end-stage renal disease, alcoholism, and decompensated cirrhosis, and in those with a liver transplant. 7


Copyright © 2002 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions


Oct 15, 2016

Access the latest issue of American Family Physician

Read the Issue

Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now

Navigate this Article